Related Experiment Videos
[Immunosuppression after organ transplantation].
1Abteilung für Nieren- und Hochdruckkrankheiten, Universitätsklinikums der Gesamthochschule Essen.
Zentralblatt Fur Chirurgie
|January 1, 1992
Summary
Organ transplant immunosuppression uses drug combinations to prevent rejection initially, but long-term survival is similar across protocols. This allows for personalized immunosuppression tailored to individual patient needs.
Area of Science:
- Immunology
- Pharmacology
- Transplantation Medicine
Background:
- Pharmacologic interventions are crucial for post-organ transplant immunosuppression.
- Commonly used drugs include steroids, azathioprine, sandimmun, and anti-T-cell globulins.
- Initial high-dose combination therapy minimizes rejection but increases infection risk.
Purpose of the Study:
- To evaluate the efficacy and outcomes of different immunosuppressive protocols in organ transplantation.
- To explore the potential for individualized immunosuppression strategies.
Main Methods:
- Review of existing immunosuppressive pharmacologic interventions.
- Analysis of outcomes during induction and long-term phases of transplantation.
- Comparison of different immunosuppressive protocols regarding patient and graft survival.
Main Results:
- High-dose combination therapy during induction reduces rejection episodes.
- Infective complications are a significant concern during the induction period.
- Long-term patient and graft survival rates are comparable across various immunosuppressive protocols.
Conclusions:
- While initial immunosuppression focuses on preventing rejection, long-term outcomes are similar regardless of the specific protocol.
- Individualized immunosuppression strategies can be developed based on the recipient's needs.
- Balancing rejection prevention with infection risk is key in immunosuppressive therapy.